Medtronic is recalling all ICDs and CRT-Ds, manufactured after 2017, with a glassed feedthrough as they may deliver low or no energy output when needed for high voltage therapy.
News | Implantable Cardioverter Defibrillator (ICD)
Medtronic Recalls ICDs and CRT-Ds for Risk of Low or No Energy Output During High Voltage Therapy

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
Quidel Cardiovascular is recalling its Quidel Triage Cardiac Panels for risk of false negative troponin results that could cause delayed diagnosis or missed myocardial infarction
News | Heart Failure
Quidel Cardiovascular Inc. Recalls Quidel Triage Cardiac Panels for Risk of False Negative Troponin Results

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on Quidel Cardiovascular is ...

Home July 18, 2023
Home
A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention
News | Artificial Intelligence
AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

Home July 18, 2023
Home
Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases
News | Cardiovascular Business
Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases

July 14, 2023 — Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire ...

Home July 14, 2023
Home
No statistical difference observed across sub-analyses for diabetes, lesion length, calcium, bailout stenting and occlusions in head-to-head study comparing Passeo-18 Lux DCB to In.Pact Admiral DCB
News | Drug-Eluting Balloons
BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon

July 14, 2023 — BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized ...

Home July 14, 2023
Home
Illustration for the deployment and shaping process of the occluder.
News | Structural Heart Occluders
Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

Home July 14, 2023
Home
Anne Snowdon, RN, PhD, FAAN
Feature | Information Technology | By Melinda Taschetta-Millane
One on One ... With Anne Snowdon, RN, PhD, FAAN

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this ...

Home July 14, 2023
Home
New service will provide rapid and comprehensive care to hundreds of heart patients every year for life-threatening emergencies and scheduled cardiac procedures.
News | Cath Lab
Mount Sinai Queens Opens New Cardiac Catheterization Lab to Expedite Care for Heart Attack Patients

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
Largest randomized trial of DynamX Bioadaptor to date with 2,400 patients enrolled, covering real-world population
News | Stents Drug Eluting
Elixir Medical Completes Enrollment of INFINITY-SWEDEHEART Clinical Trial

July 13, 2023 — Elixir Medical, a developer of breakthrough cardiovascular technologies, announced enrollment completion ...

Home July 13, 2023
Home
During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial intelligence (AI), particularly with ChatGPT, and where they think these advances are going, in a panel discussion titled AI Foundations: 2023 Update of AI in Healthcare.
Feature | Artificial Intelligence | By Melinda Taschetta-Millane
Advances in Artificial Intelligence: Experts Share Their Views

During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial ...

Home July 13, 2023
Home
To move forward in artificial intelligence, it is critical for the medical community to learn to look at solutions in multiple ways to develop a deeper sense of duality
Feature | Artificial Intelligence | By Melinda Taschetta-Millane
Discovering the Paradox of Duality at AIMed 2023

The 2023 AIMed Global Summit focused on artificial intelligence (AI) in healthcare, and offered valuable insights into ...

Home July 12, 2023
Home
CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it has received three U.S. patents for inventions that will contribute to the development of their breakthrough technology for cardiopulmonary resuscitation.
News | Sudden Cardiac Arrest
CPR Therapeutics Inc. Receives Three Patents In One Week For Innovations In Cardiopulmonary Resuscitation Technology

July 12, 2023 — CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it ...

Home July 12, 2023
Home
A subgroup analysis of the HOST-IDEA randomized controlled trial showed efficacy differences of Ultrathin Strut DES
News | Stents Drug Eluting
Late-Breaking Study Data: BIOTRONIK’s Orsiro DES Outperforms Other Ultrathin Strut Drug-Eluting Stent

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

Home July 12, 2023
Home
FIRE1 announced the start of the first U.S. clinical study of its remote heart failure monitoring system, designed to provide unique insights to the care team and alert to deteriorating patient conditions for the almost 10M Americans with HF
News | Remote Monitoring
First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study

July 11, 2023 — FIRE1 announced that the first U.S. patients have been successfully implanted with its FIRE1 System for ...

Home July 11, 2023
Home
The U.S. Food and Drug Administration (FDA) has issued a Letter to Health Care Providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD)
News | Peripheral Artery Disease (PAD)
Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

Home July 11, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now